Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Collins

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Critical Care Nurse|March 29, 2007
An exemplar of team competenceAngela Collins, Robin S Sutton, Marilyn Handley, et al.
Heliyon|July 14, 2018
The impact of <i>Staphylococcus aureus</i> genomic variation on clinical phenotype of children with acute hematogenous osteomyelitisAngela Collins, Edward K Wakeland, Prithvi Raj, et al.
Biomarker Research|May 14, 2021
Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models of Acute Myeloid LeukemiaJayna J Mistry, Charlotte Hellmich, Amelia Lambert, et al.
Leukemia|July 22, 2018
PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blastsChristopher R Marlein, Lyubov Zaitseva, Rachel E Piddock, et al.
Implementation Science Communications|April 8, 2026
Developing a national strategy to support implementation of reablement for community-dwelling people living with dementiaClaire Mc O'Connor, Sasha Houlden, Christopher J Poulos, et al.
Haematologica|March 21, 2020
Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cellsJayna J Mistry, Jamie A Moore, Prakritt Kumar, et al.
Oncogene|March 1, 2018
HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemiaAmina M Abdul-Aziz, Manar S Shafat, Yu Sun, et al.
British Journal of Haematology|August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's MacroglobulinaemiaJaimal Kothari, Toby Eyre, Ali Rismani, et al.
Annals of Hematology|February 28, 2021
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trialJames Russell, Angela Collins, Alexis Fowler, et al.
Blood|November 8, 2018
Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironmentAmina M Abdul-Aziz, Yu Sun, Charlotte Hellmich, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Critical Care Nurse|March 29, 2007
An exemplar of team competenceAngela Collins, Robin S Sutton, Marilyn Handley, et al.
Heliyon|July 14, 2018
The impact of <i>Staphylococcus aureus</i> genomic variation on clinical phenotype of children with acute hematogenous osteomyelitisAngela Collins, Edward K Wakeland, Prithvi Raj, et al.
Biomarker Research|May 14, 2021
Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models of Acute Myeloid LeukemiaJayna J Mistry, Charlotte Hellmich, Amelia Lambert, et al.
Leukemia|July 22, 2018
PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blastsChristopher R Marlein, Lyubov Zaitseva, Rachel E Piddock, et al.
Implementation Science Communications|April 8, 2026
Developing a national strategy to support implementation of reablement for community-dwelling people living with dementiaClaire Mc O'Connor, Sasha Houlden, Christopher J Poulos, et al.
Haematologica|March 21, 2020
Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cellsJayna J Mistry, Jamie A Moore, Prakritt Kumar, et al.
Oncogene|March 1, 2018
HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemiaAmina M Abdul-Aziz, Manar S Shafat, Yu Sun, et al.
British Journal of Haematology|August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's MacroglobulinaemiaJaimal Kothari, Toby Eyre, Ali Rismani, et al.
Annals of Hematology|February 28, 2021
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trialJames Russell, Angela Collins, Alexis Fowler, et al.
Blood|November 8, 2018
Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironmentAmina M Abdul-Aziz, Yu Sun, Charlotte Hellmich, et al.
Pageof 4